NSEESOP/ESOS/ESPS6d ago · 13 Aug 2026, 08:26 pm
ESOP/ESOS/ESPS
Banka BioLoo Limited · BANKA
✦ AI SummaryESG
Banka BioLoo Limited has informed the Exchange regarding the grant of 16,000 options under the Banka BioLoo Limited Employees Stock Option Plan - 2023.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Banka BioLoo Limited has informed the Exchange regarding Grant of 16000 Options.
Attachments (1)
📄pdf
Download →
BANKA_13082026202524_ESOPGrantdisclosure.pdf
View document text
BANKA BIOLOO LIMITED
Registered Office: A-109 Express Apartments, Lakdi ka Pool, Hyderabad - 500004
Corporate Office: 5th floor, Prestige Phoenix, 1405, Uma Nagar, Begumpet, Hyderabad - 500016
+91 8688825013 • info@bankabio.com • www.bankabio.com • CIN: L90001TG2012PLC082811
An ISO 9001-2015-14001-2015-45001-2018 Company
BBL/ SECT/22/2026-27
Date: 13 August 2026
The Listing Department
National Stock Exchange of India Limited,
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex, Bandra (E),
Mumbai - 400 051
NSE Symbol: BANKA
Dear Sir/Madam,
Sub: Grant of Options under the Banka BioLoo Limited Employees Stock Option Plan -
2023
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing
Regulations”), we wish to inform that the Nomination and Remuneration Committee of the
Board of Directors of the Company (“NRC”), at their meeting held on today i.e., Thursday, 13
August 2026, has approved the grant of 16,000 (Sixteen Thousand) Options under the Banka
BioLoo Limited Employees Stock Option Plan – 2023 (“Scheme”).
The disclosure pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026, and in accordance with Regulation 30 of the SEBI
Listing Regulations is annexed as Annexure 1.
The above information will also be available at the website of the Company
www.bankabio.com.
We request you to kindly take note of the same in your record.
Thank you,
For Banka BioLoo Limited
Manjula Chunduru
Company Secretary & Compliance Officer
Encl: As above
Annexure 1
Particulars Details
Brief details of options granted 16,000 (Sixteen Thousand) Options granted to
the eligible employees of the Company under
the Banka BioLoo Limited Employees Stock
Option Plan – 2023 (“Scheme”)
Whether the scheme is in terms of SEBI Yes, the scheme is in compliance with the SEBI
(SBEBASE) Regulations, 2021 (if (SBEB & SE) Regulations, 2021.
applicable)
Total number of shares covered by these 16,000 (Sixteen Thousand) Options granted shall
options be exercisable into 16,000 (Sixteen Thousand)
Equity Shares of face value Rs.10/- (Rupee Ten)
each.
Pricing Formula At face value i.e. Rs.10/- (Rupee Ten) each
Options vested Not Applicable
Vesting schedule The options would vest in the following manner:
i. Upon completion of 12 calendar months from
the date of grant; 25% of the Options shall
vest;
ii. Upon completion of 24 calendar months from
the date of grant; 25% of the Options shall
vest;
iii. Upon completion of 36 calendar months from
the date of grant; 25% of the Options shall
vest;
iv. Upon completion of 48 calendar months from
the date of grant; 25% of the Options shall
vest;
Time within which option may be The Options granted can be exercised by the
exercised eligible employee within 2 years from the date of
vesting of options.
Options exercised Not Applicable
Money realized by exercise of options Not Applicable
The total number of shares arising as a Not Applicable
result of exercise of option
Options lapsed Not Applicable
Variation of terms of options Not Applicable
Brief details of significant terms The terms of the grant of options, provides for
the manner in which options would be dealt
with, in case of death, permanent incapacity,
resignation, termination, retirement,
abandonment, etc.
The equity shares allotted, pursuant to the
exercise of the stock options, would not be
subject to lock-in.
ESOP Shares arising on the conversion of the
Options shall rank pari passu with all the other
equity Shares of the Company for the time
being in issue, from the date of allotment.
Subsequent changes or cancellation or Not Applicable
exercise of such options
Diluted earnings per share pursuant to Not Applicable
issue of equity shares on exercise of
options.